2
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Rehospitalization Risk with Second-Generation and Depot Antipsychotics

, , &
Pages 23-31 | Published online: 04 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Thomas R. Einarson, Basil G. Bereza, Fadi Tedouri, Kristel Van Impe, Tom R. Denee & Pieter J. T. Dries. (2017) Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands. Journal of Medical Economics 20:11, pages 1187-1199.
Read now
Saeed Shoja Shafti. (2017) Augmentation of aripiprazole by flupenthixol decanoate in poorly responsive schizophrenia: a randomized clinical study. Psychiatry and Clinical Psychopharmacology 27:3, pages 235-242.
Read now
Stefano Porcelli, Oriana Bianchini, Giovanni De Girolamo, Eugenio Aguglia, Luciana Crea & Alessandro Serretti. (2016) Clinical factors related to schizophrenia relapse. International Journal of Psychiatry in Clinical Practice 20:2, pages 54-69.
Read now
Marie-Hélène Lafeuille, Jason Dean, Valerie Carter, Mei Sheng Duh, John Fastenau, Riad Dirani & Patrick Lefebvre. (2014) Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia. Current Medical Research and Opinion 30:8, pages 1643-1655.
Read now
Ofer Agid, George Foussias & Gary Remington. (2010) Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention. Expert Opinion on Pharmacotherapy 11:14, pages 2301-2317.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.